|
Bionomics BNC210 Expansion into Social Anxiety Disorder
|
Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S....
Full "IntellAsia: Resources" article
|
|